The antipsychotic potential of subtype-selective 5-HT receptor ligands based on interactions with mesolimbic dopamine systems
- 1 December 1995
- journal article
- conference paper
- Published by Elsevier in Behavioural Brain Research
- Vol. 73 (1-2) , 15-17
- https://doi.org/10.1016/0166-4328(96)00064-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Ventral tegmental area 5-HT receptors: mesolimbic dopamine release and behavioural studiesPublished by Elsevier ,1999
- Molecular biology of 5-HT receptorsNeuropharmacology, 1994
- Receptors for 5-Hydroxytryptamine: Current perspectives on classification and nomenclatureNeuropharmacology, 1994
- BMY 14802, a Sigma Receptor Ligand for the Treatment of SchizophreniaNeuropsychopharmacology, 1994
- Survey on the pharmacodynamics of the new antipsychotic risperidonePsychopharmacology, 1994
- Seroquel: biochemical profile of a potential atypical antipsychoticPsychopharmacology, 1993
- Ondansetron. A double blind placebo controlled study in acute schizophreniaSchizophrenia Research, 1992
- Neurochemical and in vivo pharmacological profile of sertindole, a limbic‐selective neuroleptic compoundDrug Development Research, 1991
- Effects of the 5‐HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brainBritish Journal of Pharmacology, 1987
- Antipsychotic drug effects on the electrical activity of dopaminergic neuronsTrends in Neurosciences, 1984